Previous and current research
Our work focuses on two complementary aspects of genomics, (i) mechanisms of
epigenetic regulation in eukaryotic chromatin and (ii) technologies of genetic
engineering.
EPIGENETIC REGULATION IN CHROMATIN
Although the complete DNA sequence of an organism encodes the primary information,
additional information is added by epigenetic regulation. In eukaryotic chromatin,
epigenetic regulation is conveyed by covalent modifications of DNA (DNA methylation)
and histone tails (acetylation, phosphorylation, methylation, ubiquitinylation).
Much attention worldwide is now focused on the histone tails and the proposition
that patterns of covalent modifications serve as an epigenetic code. Our approach
to unravelling epigenetic mechanisms and hierarchies is based on complementary
uses of the yeast, S. cerevisiae and the mouse as experimental systems. We apply
advanced reverse genetic strategies, some of which were developed by us, to analyze
select classes of epigenetic regulators in both organisms. In yeast, we are using
protein-tagging and mass spectrometry to characterize complexes containing epigenetic
regulators. Amongst other complexes that we have identified in the proteomic
environment of chromatin, we have recently identified a new histone methyltransferase
activity for lysine 4 of histone 3.
In mice, we are studying two candidate histone methyltransferases by knock-out
and conditional strategies using Cre/lox, as well applying proteomic approaches
to characterize the complexes. A future aspect of our mouse work is directed
towards use of ES cell differentiation in culture as a model for epigenetic decisions
and stem cell manipulations.
GENOMIC ENGINEERING
We have developed several aspects of genetic engineering technology using site
specific and homologous recombination. We aim at more fluent manipulation of
mammalian cells, particularly ES cells and in mice. Most recent work involves
exploration and implementation of a novel homologous recombination system that
we discovered in E.coli phages. This permits fluent engineering of BACs in E.coli,
and may offer new routes for directly engineering eukaryotic cells.
Future prospects and goals
Further work on epigenetic regulators in eukaryotes will be accompanied by advanced
engineering strategies to examine roles of epigenetic regulation in mammalian
development, stem cells, ageing and disease.
Selected publications
Muyrers, JPP, Zhang, Y and Stewart AF (2001): Recombinogenic Engineering: new optionsfor manipulating DNA. Trends in Biochemical Sciences, 26: 325-331.
Schaft, J, Ashery-Padan, R, van der Hoeven, F, Gruss, P and Stewart AF (2001): Efficient FLP recombination in mouse ES cells and oocytes. Genesis, 31: 6-10.
Pijnappel, WWM, Schaft, D, Roguev, A., Tekotte, H, Shevchenko, A, Wilm, M, Rigaut, G, Séraphin, B, Aasland, R, and Stewart, AF (2001): The S. cerevisiae Set3 complex includes two histone deacetylases, Hos2 and Hst1, and is a meiotic-specific repressor of the sporulation gene program. Genes Dev., 15: 2991-3004.
Roguev, A, Schaft, D, Shevchenko, A, Pijnappel, WWM, Wilm, M, Aasland, R and Stewart, AF (2001): S. cerevisiae Set1 complex includes an Ash2-like protein and methylates histone 3 lysine 4. EMBO J., 20: (December).
Muyrers, JPP, Zhang, Y, Buchholz, F and Stewart, AF (2000): RecE/RecT and Reda/Redb initiate double stranded break repair by specifically interacting with their respective partners. Genes and Development, 14: 1971-1982.
|  |

Francis Stewart
1986: PhD at the University of N.S.W., Australia
1986-1991: Postdoctoral work at the Deutsches Krebsforschungszentrum, Heidelberg
1991-2001: Group Leader at EMBL, Heidelberg
since 2001: Professor of Genomics, Dresden University of Technology
|